Alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder

Cancer Research

Volumn 59, Issue 13, 1999, Pages 3068-3072

  Lee, Sug Hyung ^a   Shin, Min Sun ^a   Park, Won Sang ^a   Kim, Su Young ^a   Dong, Seung Myung ^a   Pi, Jae Ho ^a   Lee, Hun Kyung ^a   Kim, Ho Sik ^a   Jang, Ja June ^b   Kim, Choo Soung ^a   Kim, Sang Ho ^a   Lee, Jung Young ^a   Yoo, Nam Jin ^a  

^a The Catholic University of Korea   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

APOPTOSIS; ARTICLE; BLADDER CARCINOMA; CLINICAL ARTICLE; FRAMESHIFT MUTATION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MISSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

AMINO ACID SUBSTITUTION; ANTIGENS, CD; ANTIGENS, CD95; CARCINOMA, TRANSITIONAL CELL; DNA PRIMERS; EXONS; FAS LIGAND PROTEIN; FRAMESHIFT MUTATION; HUMANS; LOSS OF HETEROZYGOSITY; MEMBRANE GLYCOPROTEINS; MUTATION, MISSENSE; NEOPLASM STAGING; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; URINARY BLADDER NEOPLASMS;

EID: 0001130663     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Nagata, S. Apoptosis by death factor. Cell, 88: 355-365, 1997.
2. Itoh, N., and Nagata, S. A novel protein domain required for apoptosis: mutational analysis of human Fas antigen. J. Biol. Chem., 268: 10932-10937, 1993.
3. Leithäuser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Bründerlein, S . Henne, C., Schmidt, A., Debatin, K-M., Krammer, P. H., and Möller, P. Constitutive and induced expression of APO-1, a new member of the new growth factor/tumor necrosis receptor superfamily, in normal and neoplastic cells. Lab. Invest., 69: 415-429, 1993.
4. Natoli, G., Ianni, A., Costanzo, A., Petrillo, G. D., Ilari, I., Chirillo, P., Balsano, C., and Levrero, M. Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene, 11: 1157-1164, 1995.
5. Sato, T., Irie, S., Kituda, S., and Reed, J. C. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science (Washington DC), 268: 411-415, 1995.
6. Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J. L., Burns, K., Mattmann, C., Rimoldi, D., French, L. E., and Tschopp, J. Inhibition of death receptor signals by cellular FLIP. Nature (Lond.), 388: 190-195, 1997.
7. Mizutani, Y., Okada, Y., Yoshida, O., Fukumoto, M., and Bonavida, B. Doxorubicin sensitizes human bladder carcinoma cells to Fas-mediated cytotoxicity. Cancer (Phila.), 79: 1180-1189, 1997.
8. Beltinger, C., Kurz, E., Bohler, T., Schrappe, M., Ludwig, W. D., and Debatin, K. M. CD 95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia. Blood, 91: 3943-3951, 1998.
9. Tamiya, S., Etoh, K. I., Suzushima, H., Takatsuki, K., and Matsuoka, M. Mutation of CD 95(Fas/APO-1) gene in adult T-cell leukemia cells. Blood, 91: 3935-3942, 1998.
10. Landowsky, T. H., Qu, N., Buyuksal, I., Painter, J. S., and Dalton, W. S. Mutations in the Fas antigen in patients with multiple myeloma. Blood, 90: 4266-4270, 1997.
11. Grønbaek, K., Straten, P. T., Ralfkiaer, E., Ahrenkiel, V., Andersen, M. K., Hansen, N. E., Zeuthen, J., Hou-Jensen, K., and Guldberg, P. Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood, 92: 3018-3024, 1998.
12. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., and Nagata, S. Lymphoproliferalion disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (Lond.), 356: 314-317, 1992.
13. Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middleton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J., and Puck, J. M. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell, 81: 935-946, 1995.
14. Drappa, J., Vaishnaw, A. K., Sullivan, K. E., Chu, J. L., and Elkon, K. B. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N. Engl. J. Med., 335: 1643-1649, 1996.
15. Bettinardi, A., Brugnoni, B., Quiros-Roldan, E., Malagoli, A., Grutta, S. L., Correra, A., and Notarangelo, L. D. Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis. Blood, 89: 902-909, 1997.
16. Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I. A. G., Debatin, K. M., Fischer, A., de Villarty, J. P. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science (Washington DC), 268: 1347-1349, 1995.
17. Davidson, W. F., Giese, T., and Fredrickson, T. N. Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions. J. Exp. Med., 187: 1825-1838, 1998.
18. Cappellen, D., Gil Diez de Medina, S., Chopin, D., Thiery, J. P., and Radvanyi, F. Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder. Oncogene, 14: 3059-3066, 1997.
19. Mstofi, F. K., Sobin, L. H., and Torloni, H. Histological typing of urinary bladder tumors. In: International Histological Classification of Tumors, No. 10. Geneva: WHO, 1973.
20. Spiessl, B., Beahrs, O. H., Hermanek, P., Hutter, R. V. P., Scheibe, O., Sobin, L. H., and Wagnwe, G. Urinary bladder. In: TNM Atlas, Illustrated Guide to the TNM/ pTNM Classification of Malignant Tumors, Ed. 3, pp. 214-279. Berlin: Springer-Verlag Union Internationale Contre le Cancer, 1992.
21. Lee, J. Y., Dong, S. M., Kim, S. Y., Yoo, N. J., Lee, S. H., and Park, W. S. A simple, precise and economical microdissection technique for analysis of genomic DNA from archival tissue sections. Virchows Arch., 433: 305-309, 1998.
22. Fiucci, G., and Ruberti, G. Detection of polymorphisms within the Fas cDNA gene sequence by GC-clamp denaturing gradient gel electrophoresis. Immunogenetics, 39: 437-439, 1994.
23. Huang, Q. R., Morris, D., and Manolios, N. Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene. Mol. Immunol., 34: 577-582, 1997.
24. Lee, S. H., Kim, S. Y., Lee, J. Y., Shin, M. S., Dong, S. M., Na, E. Y., Park, W. S., Kim, K. M., Kim, C. S., Kim, S. H., and Yoo, N. J. Detection of soluble Fas using in situ reverse transcription-polymerase chain reaction. Lab. Invest., 78: 453-459, 1998.
25. Cairns, P., Evron, E., Okami, K., Halachmi, N., Esteller, M., Herman, J. G., Bose, S., Wang, S. I., Parsons, R., and Sidransky, D. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers. Oncogene, 16: 3215-3218, 1998.
26. Zörnig, M., Grzeschiczek, A., Kowalski, M-B., Hartmann, K-U., and Möröy, T. Loss of Fas/APO-1 receptor accelerates lymphomagenesis in Eμ L-MYC transgenic mice but not in animals infected with MoMuLV. Oncogene, 10: 2397-2401, 1995.